ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,302.49
0.24%
Dow Jones
42,208.22
0.00%
Gold vs US Dollar
2,660.175
0.06%
Brent Oil
73.365
-1.60%
Bitcoin
63,669.19
-0.93%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Delcath Systems Inc (DCTH)

  7. Delcath Systems Inc (DCTH) News

Delcath Systems (DCTH)

Delcath Systems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DCTH
DateTimeSourceHeadlineSymbolCompany
20/09/202421:01Business WireDelcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
18/09/202422:10Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DCTHDelcath Systems Inc
18/09/202422:07Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DCTHDelcath Systems Inc
16/09/202413:30Business WireDelcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma SubgroupsNASDAQ:DCTHDelcath Systems Inc
29/08/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
28/08/202421:01Business WireDelcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma PatientsNASDAQ:DCTHDelcath Systems Inc
28/08/202421:01Business WireDelcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:DCTHDelcath Systems Inc
28/08/202413:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
27/08/202413:30Business WireDelcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma PatientsNASDAQ:DCTHDelcath Systems Inc
26/08/202421:01Business WireDelcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver TumorsNASDAQ:DCTHDelcath Systems Inc
20/08/202413:30Business WireDelcath Systems Announces Poster Presentation at the 2024 ESMO CongressNASDAQ:DCTHDelcath Systems Inc
12/08/202421:01Business WireDelcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
06/08/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DCTHDelcath Systems Inc
05/08/202421:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DCTHDelcath Systems Inc
05/08/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
05/08/202421:01Business WireDelcath Systems Reports Second Quarter 2024 Results and Business HighlightsNASDAQ:DCTHDelcath Systems Inc
05/08/202413:30Business WireDelcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™NASDAQ:DCTHDelcath Systems Inc
30/07/202421:01Business WireDelcath Systems to Participate in Upcoming Investor ConferencesNASDAQ:DCTHDelcath Systems Inc
22/07/202421:01Business WireDelcath Systems to Host Second Quarter 2024 Earnings CallNASDAQ:DCTHDelcath Systems Inc
19/07/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
09/07/202416:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DCTHDelcath Systems Inc
09/07/202414:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
29/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
28/05/202421:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
28/05/202421:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
28/05/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
28/05/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
28/05/202421:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
28/05/202414:30Business WireDelcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of DirectorsNASDAQ:DCTHDelcath Systems Inc
17/05/202417:48Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DCTHDelcath Systems Inc
 Showing the most relevant articles for your search:NASDAQ:DCTH

Your Recent History

LSE
SYME
Supply@me Capital
LSE
HE1
Helium One Global
LSE
SCLP
Scancell
LSE
BIRD
Blackbird
LSE
ENET
Ethernity Networks
LSE
GDR
Genedrive
LSE
POS
Plexus
LSE
SOLG
Solgold
LSE
GKP
Gulf Keystone Petroleum
LSE
QBT
Quantum Blockchain Techn...
LSE
VAST
Vast Resources
LSE
GGP
Greatland Gold
LSE
PANR
Pantheon Resources
LSE
UPS
LSE
NEO
Neo Energy Metals
LSE
ZED
Zenova
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved